Browse Drug Recalls

1,702 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 1,702 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 1,702 FDA drug recalls, Class III.

Clear
DateProductReasonClassFirm
Mar 27, 2024 NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottl... Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month... Class III Esperion
Mar 25, 2024 Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufa... Failed Impurities/Degradation Specifications Class III Novitium Pharma LLC
Mar 4, 2024 Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufact... Cross Contamination with Other Products:(mycophenolate mofetil). Class III Novitium Pharma LLC
Feb 20, 2024 Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured fo... Defective Container: Out of specification for weight due to a slow leakage at the 12-month stabil... Class III Contract Pharmaceuticals Limited Canada
Feb 20, 2024 Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured... Defective Container: Out of specification for weight due to a slow leakage at the 12-month stabil... Class III Contract Pharmaceuticals Limited Canada
Feb 9, 2024 Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076... Failed Dissolution Specifications: results slightly under spec at at 9-months. Class III Stason Pharmaceuticals, Inc.
Feb 1, 2024 HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit d... Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged... Class III Amerisource Health Services LLC
Jan 25, 2024 Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in... Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. Class III Teva Pharmaceuticals USA, Inc
Jan 25, 2024 Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic reg... Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets. Class III Teva Pharmaceuticals USA, Inc
Jan 18, 2024 Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy'... Misprint on tablet Class III Dr. Reddy's Laboratories, Inc.
Jan 18, 2024 Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy'... Misprint on tablet Class III Dr. Reddy's Laboratories, Inc.
Dec 26, 2023 Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose c... Superpotent drug: Assay results were slightly above specification at the time zero point. Class III Amerisource Health Services LLC
Dec 12, 2023 ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg.... Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification Class III GlaxoSmithKline LLC
Dec 8, 2023 Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufa... Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylid... Class III Azurity Pharmaceuticals, Inc.
Nov 22, 2023 buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets... Failed Dissolution Specifications Class III SUN PHARMACEUTICAL INDUSTRIES INC
Nov 20, 2023 Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured ... Failed Dissolution Specifications Class III Siegfried Barbera, SL
Nov 10, 2023 Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose pack... OOS for viscosity Class III Teva Pharmaceuticals USA, Inc
Nov 10, 2023 Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25... Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL ... Class III Fagron Compounding Services
Nov 9, 2023 LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% To... Product Mix-up: Incorrect Product Formulation Class III Right Value Drug Stores, LLC dba Carie Boyd's P...
Nov 6, 2023 Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, ... Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone relat... Class III Taro Pharmaceuticals Inc.
Oct 30, 2023 V-FORCE Homeopathic, 1 FL OZ (30 ml) per glass bottle, Distributed by: BioAc... Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X i... Class III Grato Holdings, Inc.
Oct 27, 2023 Lisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-... Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet wit... Class III NCS Healthcare of Kentucky Inc
Oct 27, 2023 Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card ... Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet wit... Class III NCS Healthcare of Kentucky Inc
Oct 26, 2023 Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, M... Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution wi... Class III VistaPharm LLC
Oct 23, 2023 Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30... Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of... Class III Glenmark Pharmaceuticals Inc., USA
Oct 20, 2023 Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only,... Sub-potent Drug: Lower potency than labeled. Class III Zyla Life Sciences US Inc.
Oct 20, 2023 Opium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in... Subpotent Drug Class III Edenbridge Pharmaceuticals, LLC
Oct 20, 2023 Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-cou... Failed Impurities/Degradation Specifications Class III Glenmark Pharmaceuticals Inc., USA
Oct 17, 2023 Aminocaproic Acid Oral Solution, 0.25 grams/mL, Rx only, packaged in 8 Fl. Oz... Failed Excipient Specifications: high content of ethylene glycol (EG) Class III VistaPharm LLC
Oct 17, 2023 Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bott... Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect bar... Class III AbbVie Inc.
Oct 4, 2023 VANCOmycin HCI PF, 1.5 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx only... Labeling: Not Elsewhere Classified Class III Denver Solutions, LLC DBA Leiters Health
Oct 4, 2023 Oxytocin synthetic, 30 Units added to 0.9% Sodium Chloride 500mL IV Bag (0.06... Labeling: Not Elsewhere Classified Class III Denver Solutions, LLC DBA Leiters Health
Oct 4, 2023 Bupropion Hydrochloride Extended-Release Tablets USP (SR), 150 mg, 60 tablets... Failed Dissolution Specifications Class III SUN PHARMACEUTICAL INDUSTRIES INC
Oct 4, 2023 VANCOmycin HCI PF, 1.25 g added to 0.9% Sodium Chloride 250 mL IV Bag, Rx onl... Labeling: Not Elsewhere Classified Class III Denver Solutions, LLC DBA Leiters Health
Oct 3, 2023 Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular... Subpotent: Failing Test Results for Epinephrine Class III Imprimis NJOF, LLC
Sep 22, 2023 Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx onl... Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two ... Class III West-Ward Columbus Inc
Sep 20, 2023 MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile O... Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0%... Class III Imprimis NJOF, LLC
Sep 12, 2023 Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, S... Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product. Class III Tolmar, Inc.
Sep 7, 2023 Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouche... Subpotent: Out of Specification result observed for low assay Class III SUN PHARMACEUTICAL INDUSTRIES INC
Sep 5, 2023 Kroger Mint Burst ANTISEPTIC MOUTH RINSE ANTIGINGIVITIS/ANTIPLAQUE (Eucalypto... Incorrect/Undeclared Excipients. Class III Vi-Jon, LLC
Sep 1, 2023 HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per cart... Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged prod... Class III Amerisource Health Services LLC
Aug 29, 2023 Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 9... Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packag... Class III RB Health (US) LLC
Aug 23, 2023 Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufa... Defective Container: slow leakage under the cap Class III Contract Pharmaceuticals Limited Canada
Aug 17, 2023 Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactu... Cross contamination with other products Class III Lundbeck LLC
Aug 16, 2023 Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Man... Failed dissolution specifications: below specification results at stability 12-month Class III Esperion
Aug 14, 2023 Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL ... Failed Impurities/Degradation Specifications Class III Caplin Steriles Limited
Aug 14, 2023 Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 ... Subpotent: Out of Specification for Assay Test at the 3-month time point. Class III Glenmark Pharmaceuticals Inc., USA
Aug 14, 2023 Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial,... Labeling: Missing Label; customer complaint received that labels were partially or completely pee... Class III Baxter Healthcare Corporation
Aug 10, 2023 Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottl... Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range. Class III Imprimis NJOF, LLC
Aug 7, 2023 PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injec... Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot num... Class III Advanced Accelerator Applications USA, Inc.

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.